ACTRN12609000003279招募中2 期
A phase II trial evaluating progression free survival with cisplatin and oral vinorelbine plus radiation for Stage III Non Small Cell Lung Cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Histologically or cytologically (fine needle aspiration) proven non-small cell lung cancer
- •Performance status 0-1
- •Forced expiratory volume (FEV1) >1 Ltr
- •Adequate hematology and biochemistry
排除标准
- •Neuropathy > Grade 1
- •Uncontrolled medical disorder
- •Malabsorption syndrome
- •Women if pregnant or breast-feeding
研究者
相似试验
招募中
2 期
Everolimus Treatment in patients with Pancreatic CancerPancreatic Neuroendocrine TumoursCancer - PancreaticACTRN12612001252808Peter MacCallum Cancer Centre20
招募中
不适用
A Phase II Trial to Evaluate the Strategy of Integrating Local Ablative Therapy with First-Line Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer (RESOLUTE)metastatic colorectal cancerCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Bowel - Small bowel (duodenum and ileum)ACTRN12621001198819Cancer Council Victoria50
进行中（未招募）
不适用
A randomized phase II study of progression free survival comparing gemcitabine (1250 mg/m2 infusion) versus carboplatin (AUC5 infusion) plus alimta (500 mg/m2 infusion) as first-line chemotherapy in elderly patients with locally advanced (stage IIIb) or metastatic (stage IV) non small cell lung cancer (NSCLC) - NDEUCTR2008-002126-12-ITISTITUTO CLINICO HUMANITAS
撤回
2 期
A Phase II study of midostaurin in combination with standard chemotherapy in newly diagnosed patients with Core Binding Factor Acute Myeloid LeukaemiaACTRN12612000847819Australasian Leukaemia and Lymphoma Group50
招募中
2 期
Phase II trial of Survivin-responsive oncolytic adenovirus (Surv.m-CRA-1) by repeated intratumoral injection in advanced bone tumor patients.Advanced primary malignant bone tumorBone Neoplasms / C04Bone tumorJPRN-jRCT2073210118agano Satoshi20